Future longitudinal prospective studies on larger cohorts of cancer patients, controlled for intervention strategies and co‐morbidities, will be necessary to confirm the predictive potential of PLA2G7 in combination with other established markers for CCx diagnosis. The gene discussed is PLA2G7; the disease is cancer.